(Q86409672)

English

Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age

scientific article published on 13 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

based on heuristic

inferred from title

Srinivas Kondalsamy-Chennakesavan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Andreas Obermair

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Australian Ovarian Cancer Study Group

4

object named as

Australian Ovarian Cancer Study Group

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Andreas Hackethal

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

13 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

129

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

467-471

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

The incidental postmenopausal adnexal mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Reactivity of a monoclonal antibody with human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Comprehensive analysis of HE4 expression in normal and malignant human tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Reducing time to diagnosis does not improve outcomes for women with symptomatic ovarian cancer: a report from the Australian Ovarian Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Triage of ovarian masses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Diagnostic value of HE4 for ovarian cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.001

7 January 2021

Identifiers

10.1016/J.YGYNO.2013.03.001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23500084%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86409672&oldid=1933892801"